AI Will Decide Who Gets Access: Why Drug Contracting Is Becoming Pharma’s Most Strategic Capability​

At the World Evidence, Pricing and Access Congress 2026, Nico Mros, Founder and Chief Customer Experience Officer at Lyfegen, and Dr. Daniel Parle, Access and Contracting Strategy Lead, discussed how the growing complexity of EU market access is turning contracting into a core strategic capability for payers and pharmaceutical companies.

The session also explores how AI-enabled decision support is helping organizations move beyond static planning toward dynamic optimization, enabling more informed contracting strategies that increasingly influence patient access.

Watch the full session to see how AI-driven decision support can help teams evaluate contracting scenarios, manage complexity across markets, and make faster, more confident access decisions.

‍